Country/Region: China State/Province: Shandong
Main Products: Pharmaceutical Intermediates
Business Type: Supplier, Buying House
Year Established: 2014
Employees: 101 - 200 People
Plant Area: 50,000-100,000 square meters
Main Markets: South America 11% Africa 12% Eastern Asia 10% Domestic Market 11% North America 10% Eastern Europe 8% Southern Europe 12% Mid East 12% Northern Europe 10% Oceania 4%
Trade Capacity: FOB, EXW, DEQ
Contract Manufacturing: Buyer Label Offered
Nearest Port: Heze
Annual Revenue: US$50 Million - US$100 Million
Total Revenue: US$50 Million - US$100 Million
Export Revenue: US$50 Million - US$100 Million
Annual Output: US$50 Million - US$100 Million
Registered Capital: US$50 Million - US$100 Million
Export Percentage: 31% - 40%
Payment Modes: USD, CAD, GBP
Lead Time: 9 days
Import/Export Mode: Have Own Export License